P2RX7 and breast carcinoma: Although these conclusions derive from experimental models, anthracycline-treated breast cancer patients with mutations in the P2rx7 gene were found to develop metastatic disease faster than those with normal P2rx7 genes, suggesting the NLRP3-dependent pathway may be activated in humans with spontaneous disease (37).